High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo

• Published in: American Journal of Physiology: Cell Physiology 2010-03, Vol.298 (3), p.C465-C476
• Main Authors: Yamada, Michiko, Tatsumi, Ryuichi, Yamanouchi, Keitaro, Hosoyama, Tohru, Shiratsuchi, Sei-ichi, Sato, Akiko, Mizunoya, Wataru, Ikeuchi, Yoshihide, Furuse, Mitsuhiro, Allen, Ronald E
• Format: Article
• Language: English
• Subjects: Animals; Antibodies; Blotting, Western; Cell cycle; Cell Proliferation - drug effects; Cells, Cultured; Cellular Senescence - drug effects; Cyclin-Dependent Kinase Inhibitor p21 - metabolism; Dose-Response Relationship, Drug; Feedback, Physiological; Gene expression; Hepatocyte Growth Factor - metabolism; Hepatocyte Growth Factor - pharmacology; Humans; Kinases; Male; Muscle Cell Biology and Cell Motility; Muscle Development - drug effects; Musculoskeletal system; Myostatin - genetics; Myostatin - immunology; Myostatin - metabolism; Physiology; Proteins; Rats; Rats, Sprague-Dawley; Recombinant Proteins - metabolism; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger - metabolism; Satellite Cells, Skeletal Muscle - drug effects; Satellite Cells, Skeletal Muscle - metabolism; Signal Transduction; Time Factors; Up-Regulation
• ISSN: 0363-6143; 1522-1563
• DOI: 10.1152/ajpcell.00449.2009

Skeletal muscle regeneration and work-induced hypertrophy rely on molecular events responsible for activation and quiescence of resident myogenic stem cells, satellite cells. Recent studies demonstrated that hepatocyte growth factor (HGF) triggers activation and entry into the cell cycle in response to mechanical perturbation, and that subsequent expression of myostatin may signal a return to cell quiescence. However, mechanisms responsible for coordinating expression of myostatin after an appropriate time lag following activation and proliferation are not clear. Here we address the possible role of HGF in quiescence through its concentration-dependent negative-feedback mechanism following satellite cell activation and proliferation. When activated/proliferating satellite cell cultures were treated for 24 h beginning 48-h postplating with 10-500 ng/ml HGF, the percentage of bromodeoxyuridine-incorporating cells decreased down to a baseline level comparable to 24-h control cultures in a HGF dose-dependent manner. The high level HGF treatment did not impair the cell viability and differentiation levels, and cells could be reactivated by lowering HGF concentrations to 2.5 ng/ml, a concentration that has been shown to optimally stimulate activation of satellite cells in culture. Coaddition of antimyostatin neutralizing antibody could prevent deactivation and abolish upregulation of cyclin-dependent kinase (Cdk) inhibitor p21. Myostatin mRNA expression was upregulated with high concentrations of HGF, as demonstrated by RT-PCR, and enhanced myostatin protein expression and secretion were revealed by Western blots of the cell lysates and conditioned media. These results indicate that HGF could induce satellite cell quiescence by stimulating myostatin expression. The HGF concentration required (over 10-50 ng/ml), however, is much higher than that for activation, which is initiated by rapid release of HGF from its extracellular association. Considering that HGF is produced by satellite cells and spleen and liver cells in response to muscle damage, local concentrations of HGF bathing satellite cells may reach a threshold sufficient to induce myostatin expression. This time lag may delay action of the quiescence signaling program in proliferating satellite cells during initial phases of muscle regeneration followed by induction of quiescence in a subset of cells during later phases.